Cervical Plexus Versus Infiltration for Clavicular Operations (CERPICO)
Launched by NAVAL MEDICAL CENTER CAMP LEJEUNE · Dec 11, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
ALL PATIENTS (STANDARD CARE)
Patients will be administered a standardized anesthetic plan of preoperative anxiolysis (midazolam 2mg) and induction of anesthesia (lidocaine 1-1.5mg/kg, fentanyl 0.5-1.5mcg/kg, propofol 1-3mg/kg, and rocuronium 0.6-1.2mg/kg). Airway management will be at the discretion of the staff anesthesia provider.
Following endotracheal intubation, the anesthesia provider will perform an ultrasound-guided intermediate cervical plexus block. Ultrasound imaging will be used to identify the sternocleidomastoid muscle at its midpoint between origin and insertion. An echogen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-64 years
- • Scheduled surgery of the clavicle, acromioclavicular joint, or coracoclavicular ligament at NMCL
- • ASA Physical Status Classification 1-3
- Exclusion Criteria:
- • Emergent surgery
- • Concurrent surgery involving the glenobumeral joint or proximal humerus
- • Prior anaphylactic reaction or known intolerance to study medications
- • Patient reported or documented opioid use within the last 30 days unrelated to clavicular, AC joint, or CC ligament pathology
About Naval Medical Center Camp Lejeune
Naval Medical Center Camp Lejeune is a premier military healthcare facility dedicated to providing comprehensive medical services to active-duty personnel, veterans, and their families. As a clinical trial sponsor, the center is committed to advancing medical research and improving patient outcomes through innovative studies in various fields, including trauma care, mental health, and chronic disease management. By leveraging its expertise and resources, Naval Medical Center Camp Lejeune aims to contribute valuable insights to the medical community while ensuring the highest standards of safety and ethical conduct in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Camp Lejeune, North Carolina, United States
Patients applied
Trial Officials
CDR Lee, MD
Principal Investigator
DHA/MD365
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported